Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WTF has been going on since 2017 with PMA bullshit? Epic morons, as you call them, should consider and understand this. I have not seen one bit of evidence suggesting anything has ever changed since then. Does anyone care to explain what has been going on since 2017 that will garner FDA approval (besides the fraud the SEC uncovered which seems to be the only activity)?
"There will be no failure. Only epic morons think this. Surgicrap is a total disgrace which was never approved by the FDA and was grandfathered in and has so many side effects that they’ve had multiple lawsuits against it. The FDA has been carrying us to the finish line, which I finally realized. They could’ve reset the clock on us 10 to 20 times but they never did because they realize Surgicrap is an embarrassment and they want that product out of there."
"FDA Selects HemoStyp ® for CtQ Pilot Program
Henderson, Nevada – December 4, 2017 –United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it is proceeding with its application for HemoStyp under the FDA’s new and innovative CtQ Pilot Program. The FDA selected UHP’s HemoStyp as only one of nine participants for the program. UHP management has scheduled its first face-to-face meeting with FDA experts for January 17, 2018 to provide the agency with whatever information it needs to advance the application for premarket approval (PMA).
The FDA has stated that it intends to work collaboratively with pilot program participants during the review of their PMA submission to define characteristics of the device that are critical to product quality, and how these characteristics are controlled in design and manufacturing prior to the postmarket inspection. For pilot program participants, the FDA would forego conducting the standard PMA preapproval inspection, and a postmarket inspection focusing on the PMA applicant’s implementation of the critical to quality characteristics would be conducted instead.
The CtQ Pilot Program was created to identify products that have a chemical makeup of demonstrated safe interaction with the body –as evidenced by years of prior product usage and studies-- to be approved for Class III internal surgical use. The program’s intent is to allow products that have demonstrated repeated safe interaction to enter the market in a more efficient manner. This application will run simultaneously with the company’s prior Class II application for expanded indication. The market for 2017 internal surgical market for hemostatic products is estimated at in excess of seven billion dollars, and is expected to grow at 7.1% over the next few years, to reach more than $8.3 billion by 2022. (http://industryarc.com/Report/15189/hemostats-market.html)
Concurrent with its CtQ Pilot Program participation, UHP reaffirms that its current Class II application – Expanded Indication submission with the US FDA-- continues to progress, and is in an advanced stage of review
About Premarket Approval Application Critical to Quality (PMA CtQ) Pilot Program
Top-quality medical devices help the FDA better protect and promote public health. And one of the top priorities for FDA’s medical devices center is a focus on quality.
More specifically, the FDA is working with stakeholders—industry, health care providers, patients, payers, and investors—to build a strong Case for Quality.
This program allows the FDA to identify device manufacturers that consistently produce high-quality devices. By doing so, we can better focus our resources helping other manufacturers raise their level of quality. This program also helps the FDA identify and promote practices that support consistent quality manufacturing, and align our regulatory, enforcement, compliance approaches with those practices.
The FDA launched the Case for Quality in 2011 following an in-depth review of device quality data and feedback from both FDA and industry stakeholders. The FDA’s analysis flagged certain widespread or common manufacturing risks that impact product quality. The review also showed manufacturers that focus on and manage those risks often become more productive, receiving fewer complaints, needing to open fewer CAPAs and investigations, and having lower quality-related product costs than their competitors.
In simple terms, the review identified that an investment in quality has long-term payoffs."
Why doesn't Thom want his clients to know he is CEO of a stock scam? He does not list it on his write up with Waveny Partners.
https://www.butlercap.com/our-team-2
Brian Thom
Alternative Asset Sales for Butler Capital and Principal of Waveny Partners, Alternative Asset Management Firm
Previous Experience
Capital Placement Practitioner and Advisor to Corporate Clients for Butler Capital and Principal of Waveny Partners
Head of Corporate Finance for the Americas with Société Générale
Managing Director at FBR & Co. Leading M&A and equity capital raising transactions in the Energy sector
Global Mergers & Acquisitions group at JPMorgan
Meanwhile the CEO is employed at Butler Capital on the other side of the country:
https://brokercheck.finra.org/individual/summary/4231884
Does he do anything more than manipulate the unrealistically high price of this stock scam?
https://www.butlercap.com/our-team-2
Brian Thom
Alternative Asset Sales for Butler Capital and Principal of Waveny Partners, Alternative Asset Management Firm
Previous Experience
Capital Placement Practitioner and Advisor to Corporate Clients for Butler Capital and Principal of Waveny Partners
Head of Corporate Finance for the Americas with Société Générale
Managing Director at FBR & Co. Leading M&A and equity capital raising transactions in the Energy sector
Global Mergers & Acquisitions group at JPMorgan
Master in Business Administration from McMaster University
Confirmation of UHP headquarters: UHP headquarters map and photo
https://uhpcorp.com/contact-us/
Stop by and get a u-haul in the desert instead of bandages?
3 including you.😉
"Another Green Day…….how nice!"
This must be closer to airing than you think for it to be up on this page:
https://briangartlandentertainment.com/
Neither Mr. Blagman nor Mr. Gartland come off as scammers when you look at the way they have conducted themselves throughout their lives.
"An expert in his field, Mr. Gartland holds a Bachelor of Arts in business marketing and economics from The Ohio State University. In recognition of his professional accomplishments, he won a Community Impact Award, a Most Innovative Award, and the Most Improved Center Award. Likewise, he earned the Best Brand Partnership in the World for "Home Alone Again" through 20th Century Fox. While his career has been filled with highlights, he takes the most pride in obtaining the aforementioned partnership. Once the commercial launched, it went viral quickly. Another highlight was updating the film "Miracle on 34th Street" for its 70th anniversary in order to help it resonate with a younger audience. In the coming years, Mr. Gartland intends to retire and open an animal sanctuary, as well as travel more."
More groundless and unsubstantiated bullshit from rodman.
Sure you are. Amazing how many first time posters have shown up lately. How telling when you refer to facts and links from reputable sources like the SEC as noise.
You just know Crown Royal is jumping at this.
What lies are those surf? Is Brian Gartland a conspirator?
"No, as that page has been up for months with the lies!"
https://briangartlandentertainment.com/hollywood-after-dark/ Disappointed surf? They must still be planning on doing something with this for it to be up on this website. Look at this page...it is displayed prominently with a lot of well know shows; https://briangartlandentertainment.com/
There is no company to contact. The whole thing is a dirty broker run scam and so are you. Only an idiot would contact dirty brokers running a sham.
Herd949
Level Icon
Followers 0
Posts 2
Boards Moderated 0
Alias Born 02/12/2024
It won't take much to move this. You can tell by the shallow volume that has moved the bid/ask from.0001/.0002 to .0002/.0003 repeatedly this winter. If contracts for HAD start getting announced, mwwc will make enormous gains. Hopefully, the silence gets broken with good news.
Who the eff are you bullshitting? A dirty broker threw $20 at the last minute to bullshit everyone. Dirty brokers are so desperate. They must have clients $$$$ tied up in this scam and trying desperately not to take heavy losses.
UEEC
United Health Products, Inc.
Common Stock
0.20115
0.00125
0.63%
0.1862 / 0.2092 (1 x 1)
TRADE DATA
DATE TIMESTAMP PRICE $ CHANGE VOLUME
03/28/2024 15:56:59 0.20115 0.02 100
03/28/2024 14:56:07 0.1841 -0.03 749
Who the eff are you bullshitting? Throw $20 at the last minute to bullshit everyone corrupt clown. You jackasses are so desperate. Do you dirty brokers have your clients $$$$ tied up in this scam and trying not to take heavy losses?
UEEC
United Health Products, Inc.
Common Stock
0.20115
0.00125
0.63%
0.1862 / 0.2092 (1 x 1)
TRADE DATA
DATE TIMESTAMP PRICE $ CHANGE VOLUME
03/28/2024 15:56:59 0.20115 0.02 100
03/28/2024 14:56:07 0.1841 -0.03 749
"Just seen the trailer for the remake of roadhouse. Proves my point exactly, there is no originality left in Hollywood."
"That’s why I’ve had my doubts about HAD. Honestly I don’t think there’s any demand for it."
"Who makes two seasons of a reality show and does zero publicity or promote it on social media. JMHO."
"Tell me where I’m wrong."
Angels; do you volunteer to do the welfare check?
"Looks like Blagman has"
What could possibly go wrong or change between now and then?
"I dont think you can tweet Lionsgate without something actually about to happen with them.... Lawyers would have not allowed him to do the things he is doing unless it was on the up and up. Use some logic."
He just tweeted 2 days ago: March 26
Yup. That's my sense too.
"Of course will get fucked"
"Means NOTHING"
You're just embarrassing yourself pretending this isn't a scam that hoodwinks gullible suckers.
You had full FDA submission in 2017...what's changed?
https://www.otcmarkets.com/filing/html?id=12414685&guid=4td-kaJ6H_M4B3h#UEEC_EX991_HTM
"FDA Selects HemoStyp ® for CtQ Pilot Program
Henderson, Nevada – December 4, 2017 –United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it is proceeding with its application for HemoStyp under the FDA’s new and innovative CtQ Pilot Program. The FDA selected UHP’s HemoStyp as only one of nine participants for the program. UHP management has scheduled its first face-to-face meeting with FDA experts for January 17, 2018 to provide the agency with whatever information it needs to advance the application for premarket approval (PMA).
The FDA has stated that it intends to work collaboratively with pilot program participants during the review of their PMA submission to define characteristics of the device that are critical to product quality, and how these characteristics are controlled in design and manufacturing prior to the postmarket inspection. For pilot program participants, the FDA would forego conducting the standard PMA preapproval inspection, and a postmarket inspection focusing on the PMA applicant’s implementation of the critical to quality characteristics would be conducted instead.
The CtQ Pilot Program was created to identify products that have a chemical makeup of demonstrated safe interaction with the body –as evidenced by years of prior product usage and studies-- to be approved for Class III internal surgical use. The program’s intent is to allow products that have demonstrated repeated safe interaction to enter the market in a more efficient manner. This application will run simultaneously with the company’s prior Class II application for expanded indication. The market for 2017 internal surgical market for hemostatic products is estimated at in excess of seven billion dollars, and is expected to grow at 7.1% over the next few years, to reach more than $8.3 billion by 2022. (http://industryarc.com/Report/15189/hemostats-market.html)
Concurrent with its CtQ Pilot Program participation, UHP reaffirms that its current Class II application – Expanded Indication submission with the US FDA-- continues to progress, and is in an advanced stage of review
About Premarket Approval Application Critical to Quality (PMA CtQ) Pilot Program
Top-quality medical devices help the FDA better protect and promote public health. And one of the top priorities for FDA’s medical devices center is a focus on quality.
More specifically, the FDA is working with stakeholders—industry, health care providers, patients, payers, and investors—to build a strong Case for Quality.
This program allows the FDA to identify device manufacturers that consistently produce high-quality devices. By doing so, we can better focus our resources helping other manufacturers raise their level of quality. This program also helps the FDA identify and promote practices that support consistent quality manufacturing, and align our regulatory, enforcement, compliance approaches with those practices.
The FDA launched the Case for Quality in 2011 following an in-depth review of device quality data and feedback from both FDA and industry stakeholders. The FDA’s analysis flagged certain widespread or common manufacturing risks that impact product quality. The review also showed manufacturers that focus on and manage those risks often become more productive, receiving fewer complaints, needing to open fewer CAPAs and investigations, and having lower quality-related product costs than their competitors.
In simple terms, the review identified that an investment in quality has long-term payoffs."
Looks like, once again, I am telling the truth. Butler Capital even lists him as working there. I'm just trying to clear things up so the marks for this Ponzi Scheme aren't mislead by pathological sociopaths. Certainly, you understand that, don't you dr5?
Next we visit Butler's website:
Brian Thom
Alternative Asset Sales for Butler Capital and Principal of Waveny Partners, Alternative Asset Management Firm
Previous Experience
Capital Placement Practitioner and Advisor to Corporate Clients for Butler Capital and Principal of Waveny Partners
Head of Corporate Finance for the Americas with Société Générale
Managing Director at FBR & Co. Leading M&A and equity capital raising transactions in the Energy sector
Global Mergers & Acquisitions group at JPMorgan
Master in Business Administration from McMaster University
The link tells a different story. Who should we believe; you or the link? It says Thom is an active broker at Butler Capital Partners.
https://brokercheck.finra.org/individual/summary/4231884
BUTLER CAPITAL PARTNERS (CRD# 114242)
2022 - Present (1 year)
Current Registration(s)
B
BUTLER CAPITAL PARTNERS (CRD#:114242)
151 Post Road Titus House, OLD WESTBURY, NY 11568
Registered with this firm since 11/11/2022
What specifically is not true? Is that not the address UHP gives as "headquarters" on their website? Do these links bother and trouble you? Name every employee and tell us their responsibilities? Tell us what has changed with the PMA's between 2017 and now?
You seem pretty upset for someone who owns stock in a wonderful company that does wonderful business. Why? Can't you just sit back and let the market respond to this wonderful product with wonderful sales? You should be on top of the world being a shareholder as you inform us you are.
This guy right here is in charge?: https://brokercheck.finra.org/individual/summary/4231884
He must be doing a lot as CEO of UHP while sitting behind the desk of a totally different company. And you say Beplate has nothing to do with it? Who picked this stockbroker to be "CEO"?
And at the other end of the country from Thom is UHP headquarters:
526 Commerce Circle, Suite 120 Mesquite, NV 89027
Nice Suite. What a wonderful professional location. It's very accessible. I bet potential clients are really impressed by the selection of u-hauls when they make their way to meet Mr. CEO Brian Thom in the u-haul showroom and discuss business. You can see all the effort into finding business partners at this serious operation. A whole lot of constructive activity must be getting done at UHP. Does Thom do anything besides manipulate the price, regurgitate old PR's with a few words changed, and sell stock? What really has changed? A few names change, like a few words change, in a regurgitated PR? 3 years ago it seems Beplate had over 30 million shares. What happened to them? Why is nothing to do with this so-called company verifiable? I never see any answers into what has changed since the 2017 PMA and now. This whole thing is beyond fishy.
Transaction
Date Reported DateTime Exercisable Expiration Company Symnbol Insider Relationship Shares Traded Conversion Price Shares Owned Filing
2019-11-05 Option Award 2021-08-06 5:22 pm N/A N/A United Health Products Inc. UEEC BEPLATE DOUGLAS K CEO 400,000 $0.97 712,142
(Direct) View
2021-01-06 Option Award 2021-01-11 4:30 pm N/A N/A United Health Products Inc. UEEC BEPLATE DOUGLAS K Director 10% Owner 30,730,000 $0.56 35,805,142 (Direct) View
2020-11-30 Option Award(A) 2020-12-04 5:00 pm N/A N/A United Health Products Inc. UEEC BEPLATE DOUGLAS K Former CEO 40,000 $0 360,000
(Direct) View
2020-11-30 Option Award 2020-12-02 5:00 pm N/A N/A United Health Products Inc. UEEC BEPLATE DOUGLAS K Former CEO 40,000 $0 311,444
(Direct) View
2020-09-30 Option Award 2020-11-20 4:00 pm N/A N/A United Health Products Inc. UEEC BEPLATE DOUGLAS K Chief Executive Officer 147,750 $0 390,000
(Direct) View
2020-07-21 Option Award 2020-07-30 7:46 pm N/A N/A United Health Products Inc. UEEC BEPLATE DOUGLAS K Chief Executive Officer 5,070,000 $0.71 5,075,142
(Direct) View
https://www.secform4.com/insider-trading/1256745.htm
As unthinkable as it is, maybe your word Beplate has nothing to do with this is not very believable. It's just hard to believe someone with so many shares in a non-existent enterprise is not lurking about.
Who is? Is it up for sale?